New York, NYNCT06168058Now EnrollingIRB Ready

Chronic Pelvic Pain Syndrome Clinical Trial in New York, NY

Access cutting-edge chronic pelvic pain syndrome treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Weill Medical College of Cornell University

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access chronic pelvic pain syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic pelvic pain syndrome treatment provided free

Apply for This New York Location

Check if you qualify for this chronic pelvic pain syndrome clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Chronic Pelvic Pain Syndrome Study in New York

The purpose of this study is to see if a randomized controlled trial of ovarian vein and pelvic vein embolization versus venography alone could determine outcomes for women with chronic pelvic pain and pelvic varicose veins. The data gathered will assist in addressing changes in quality of life in patients who have ovarian/pelvic vein embolization versus no embolization.

Sponsor: Weill Medical College of Cornell University

Who Can Participate

Inclusion Criteria

Presence of venous origin chronic pelvic pain for greater than 6 months (VAS ≥7 as determined by 4 consecutive weeks of baseline self-assessments) despite non-vascular therapy as delineated by the following criteria:
Pain exacerbated by walking, standing or lifting
Symptoms are at least partially alleviated by lying down
Prolonged post-coital ache
Absence of non-venous origin CPP as determined by Gynecology examination
Symptoms-Varices-Pathophysiology Classification18 including of one of the following: •S2V2PBGV,R,NT, S2V2PRGV,R,NT , S2V2PLGV,R,NT, with or without S2V2 PBIIV,R,NT, S2V2 PLIIV,R,NT, S2V2 PRIIV,R,NT
CT, TAUS and diagnostic venography (if needed) imaging review for pelvic venous imaging factors
Left or right ovarian vein diameter greater than or equal to 6 mm as documented by TAUS or CT
Presence of intrabdominal/pelvic varices as documented by TAUS or CT (≥1 veins, \>5 mm diameter)
Presence of venous reflux in ovarian and/or internal iliac veins without evidence of hemodynamically significant stenosis

Exclusion Criteria

Female \<18 years of age
Pregnancy (positive pregnancy test)
Female subject who plans to become pregnant during study period
Female subject who is actively breastfeeding
Patient who is post-menopausal or anovulatory with hormone suppression
History of prior hysterectomy
Prior ovarian vein embolization or ovarian vein ligation
Inability to tolerate endovascular procedure due to acute illness or general health
Planned simultaneous treatment with nerve blocks during the duration of the study
Laparoscopy or planned surgical intervention during the duration of the study
Known allergy to sclerosant, coil, stent or catheter components including nickel allergy
Any iliac vein stenosis determined identified by the investigator on pelvic DUS, CT venogram, and/or Catheter Venography and deemed significant for exclusion by study patient review committee.
Any renal vein stenosis with resultant renal hilar varices/collaterals and lumbar collaterals identified by the investigator on pelvic DUS, CT venogram, and/or Diagnostic Venography and deemed significant for exclusion by study patient review committee.
Presence of isolated extra-pelvic vulvar and/or lower extremity varices without intrabdominal pelvic varices. Primary S3 categorization study exclusion.
Serious medical conditions that might preclude full participation in the study to the desired endpoint (e.g., uncontrolled diabetes, malignancy, COPD, MI, CHF, etc.)
Severe allergy to iodinated or gadolinium-based contrast refractory to steroid premedication
Severe renal impairment (on chronic dialysis or estimated GFR \<30 mL/min)
Hemoglobin \<8.0 g/dL, uncorrectable INR \>3.0 or platelet count \<75,000/microliter
Inability to provide informed consent or to comply with study assessments
Post thrombotic IVC, iliac or ovarian vein changes

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06168058) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Pelvic Pain Syndrome Treatment Options in New York, NY

If you're searching for chronic pelvic pain syndrome treatment options in New York, NY, this clinical trial (NCT06168058) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic pelvic pain syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic pelvic pain syndrome clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in New York, NY

See all pulmonary embolism clinical trials recruiting in New York — not just this study.

Browse Pulmonary Embolism Trials in New York →

Browse More Trials by Condition

Pulmonary Embolism TrialsChronic Pain TrialsInterstitial Cystitis TrialsEndometriosis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY